These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 24627525)
1. The CD47-SIRPα signalling system: its physiological roles and therapeutic application. Murata Y; Kotani T; Ohnishi H; Matozaki T J Biochem; 2014 Jun; 155(6):335-44. PubMed ID: 24627525 [TBL] [Abstract][Full Text] [Related]
2. Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway. Murata Y; Saito Y; Kaneko T; Kotani T; Kaneko Y; Ohnishi H; Matozaki T Methods; 2014 Jan; 65(2):254-9. PubMed ID: 24091004 [TBL] [Abstract][Full Text] [Related]
3. Functions and molecular mechanisms of the CD47-SIRPalpha signalling pathway. Matozaki T; Murata Y; Okazawa H; Ohnishi H Trends Cell Biol; 2009 Feb; 19(2):72-80. PubMed ID: 19144521 [TBL] [Abstract][Full Text] [Related]
4. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. Barclay AN; Van den Berg TK Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318 [TBL] [Abstract][Full Text] [Related]
5. Essential roles of SIRPα in homeostatic regulation of skin dendritic cells. Iwamura H; Saito Y; Sato-Hashimoto M; Ohnishi H; Murata Y; Okazawa H; Kanazawa Y; Kaneko T; Kusakari S; Kotani T; Nojima Y; Matozaki T Immunol Lett; 2011 Mar; 135(1-2):100-7. PubMed ID: 20955735 [TBL] [Abstract][Full Text] [Related]
6. Role for CD47-SIRPalpha signaling in xenograft rejection by macrophages. Ide K; Wang H; Tahara H; Liu J; Wang X; Asahara T; Sykes M; Yang YG; Ohdan H Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5062-6. PubMed ID: 17360380 [TBL] [Abstract][Full Text] [Related]
7. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Chen J; Zhong MC; Guo H; Davidson D; Mishel S; Lu Y; Rhee I; Pérez-Quintero LA; Zhang S; Cruz-Munoz ME; Wu N; Vinh DC; Sinha M; Calderon V; Lowell CA; Danska JS; Veillette A Nature; 2017 Apr; 544(7651):493-497. PubMed ID: 28424516 [TBL] [Abstract][Full Text] [Related]
8. Soluble extracellular domains of human SIRPα and CD47 expressed in Escherichia coli enhances the phagocytosis of leukemia cells by macrophages in vitro. Lin Y; Yan XQ; Yang F; Yang XW; Jiang X; Zhao XC; Zhu BK; Liu L; Qin HY; Liang YM; Han H Protein Expr Purif; 2012 Sep; 85(1):109-16. PubMed ID: 22813925 [TBL] [Abstract][Full Text] [Related]
9. "Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein α (SIRPα) antagonists that enhance antibody-dependent cellular phagocytosis. Ho CC; Guo N; Sockolosky JT; Ring AM; Weiskopf K; Özkan E; Mori Y; Weissman IL; Garcia KC J Biol Chem; 2015 May; 290(20):12650-63. PubMed ID: 25837251 [TBL] [Abstract][Full Text] [Related]
10. Signal regulatory protein alpha ligation induces macrophage nitric oxide production through JAK/STAT- and phosphatidylinositol 3-kinase/Rac1/NAPDH oxidase/H2O2-dependent pathways. Alblas J; Honing H; de Lavalette CR; Brown MH; Dijkstra CD; van den Berg TK Mol Cell Biol; 2005 Aug; 25(16):7181-92. PubMed ID: 16055727 [TBL] [Abstract][Full Text] [Related]
11. [Role of CD47 in hematologic malignancies]. Su GH; Zhao YL Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Dec; 21(6):1631-4. PubMed ID: 24370062 [TBL] [Abstract][Full Text] [Related]
12. Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction. Lundberg P; Koskinen C; Baldock PA; Löthgren H; Stenberg A; Lerner UH; Oldenborg PA Biochem Biophys Res Commun; 2007 Jan; 352(2):444-8. PubMed ID: 17126807 [TBL] [Abstract][Full Text] [Related]
13. Loss of Cell Surface CD47 Clustering Formation and Binding Avidity to SIRPα Facilitate Apoptotic Cell Clearance by Macrophages. Lv Z; Bian Z; Shi L; Niu S; Ha B; Tremblay A; Li L; Zhang X; Paluszynski J; Liu M; Zen K; Liu Y J Immunol; 2015 Jul; 195(2):661-71. PubMed ID: 26085683 [TBL] [Abstract][Full Text] [Related]
14. Enhanced phagocytosis of CD47-deficient red blood cells by splenic macrophages requires SHPS-1. Ishikawa-Sekigami T; Kaneko Y; Saito Y; Murata Y; Okazawa H; Ohnishi H; Oldenborg PA; Nojima Y; Matozaki T Biochem Biophys Res Commun; 2006 May; 343(4):1197-200. PubMed ID: 16580635 [TBL] [Abstract][Full Text] [Related]
15. Exosome-SIRPα, a CD47 blockade increases cancer cell phagocytosis. Koh E; Lee EJ; Nam GH; Hong Y; Cho E; Yang Y; Kim IS Biomaterials; 2017 Mar; 121():121-129. PubMed ID: 28086180 [TBL] [Abstract][Full Text] [Related]
16. Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. Tsai RK; Rodriguez PL; Discher DE Blood Cells Mol Dis; 2010 Jun; 45(1):67-74. PubMed ID: 20299253 [TBL] [Abstract][Full Text] [Related]
18. Cancer immunotherapy targeting the CD47/SIRPα axis. Weiskopf K Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286 [TBL] [Abstract][Full Text] [Related]
19. Functional elements on SIRPalpha IgV domain mediate cell surface binding to CD47. Liu Y; Tong Q; Zhou Y; Lee HW; Yang JJ; Bühring HJ; Chen YT; Ha B; Chen CX; Yang Y; Zen K J Mol Biol; 2007 Jan; 365(3):680-93. PubMed ID: 17070842 [TBL] [Abstract][Full Text] [Related]
20. CD47-SIRPα Interactions Regulate Macrophage Uptake of Plasmodium falciparum-Infected Erythrocytes and Clearance of Malaria In Vivo. Ayi K; Lu Z; Serghides L; Ho JM; Finney C; Wang JCY; Liles WC; Kain KC Infect Immun; 2016 Jul; 84(7):2002-2011. PubMed ID: 27091932 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]